Washington, DC, February 26, 2016 --(PR.com
)-- Clinical Research Forum is elated that its prior Chair and one of its co-founders, Dr. Robert Califf, MD, was confirmed by the Senate on a vote of 89 to 4 as Commissioner of the U.S. Food and Drug Administration (FDA). The FDA and the nation are lucky, and Clinical Research Forum is very proud.
Harry P. Selker, MD, MSPH, Chair, Clinical Research Forum said, “We congratulate Rob on his appointment and thank him for his service to our organization and now to our country. We know that many will be the beneficiaries of his work, but most importantly, the public and patients who depend on the wide array of FDA’s domain. The FDA and our nation are lucky to have him as Commissioner!”
The FDA is the agency of the U.S. Department of Health and Human Services that protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation's food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products.
In addition to serving as the former Chair of the Board for the Clinical Research Forum, Dr. Califf was Vice Chancellor of Clinical and Translational Research and the Director of the Duke Translational Medicine Institute. President Obama nominated Dr. Califf five months ago and already his impact has been saluted by many. His priority as Commissioner will be to streamline the clinical trial process to increase efficiency and lower costs. He also plans to create a post-market surveillance system for medical devices that mirrors the one in place for drugs.